Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Baudin

Showing results (111-120 of 241) with videos related to

Pageof 25
Sort By:
Endocrine|October 31, 2020
Impact of expert review of histological diagnosis of papillary and follicular thyroid cancerSegolene Hescot, Hala Sheikh-Alard, Manal Kordahi, et al.
The Journal of Clinical Endocrinology and Metabolism|January 4, 2011
Performance of (18)fluorodeoxyglucose-positron emission tomography and somatostatin receptor scintigraphy for high Ki67 (≥10%) well-differentiated endocrine carcinoma stagingRonan Abgral, Sophie Leboulleux, Désirée Déandreis, et al.
Neuroendocrinology|June 9, 2020
Long-Term Results after Surgical Resection of Peritoneal Metastasis from Neuroendocrine TumorsLéonor Benhaim, Matthieu Faron, Julien Hadoux, et al.
Endocrine-Related Cancer|February 26, 2009
Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinomaCosimo Durante, Houda Boukheris, Clarisse Dromain, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
Bevacizumab plus capecitabine in patients with progressive advanced well-differentiated neuroendocrine tumors of the gastro-intestinal (GI-NETs) tract (BETTER trial)--a phase II non-randomised trialEmmanuel Mitry, Thomas Walter, Eric Baudin, et al.
The Journal of Clinical Endocrinology and Metabolism|March 31, 2017
Surgery for Neck Recurrence of Differentiated Thyroid Cancer: Outcomes and Risk FactorsLivia Lamartina, Isabelle Borget, Haitham Mirghani, et al.
Oncotarget|January 5, 2018
Identifying mitotane-induced mitochondria-associated membranes dysfunctions: metabolomic and lipidomic approachesSégolène Hescot, Larbi Amazit, Marie Lhomme, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 15, 2011
Magnetic resonance imaging versus endoscopic ultrasonography for the detection of pancreatic tumours in multiple endocrine neoplasia type 1Coralie Barbe, Arnaud Murat, Benoit Dupas, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 12, 2022
Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survivalArnaud Jannin, Livia Lamartina, Coralie Moutarde, et al.
Endocrinology, Diabetes & Metabolism Case Reports|June 15, 2016
Dyslipidemia causes overestimation of plasma mitotane measurementsAngelo Paci, Ségolène Hescot, Atmane Seck, et al.
Pageof 25

Showing results (111-120 of 241) with videos related to

Sort By:
Pageof 25
Endocrine|October 31, 2020
Impact of expert review of histological diagnosis of papillary and follicular thyroid cancerSegolene Hescot, Hala Sheikh-Alard, Manal Kordahi, et al.
The Journal of Clinical Endocrinology and Metabolism|January 4, 2011
Performance of (18)fluorodeoxyglucose-positron emission tomography and somatostatin receptor scintigraphy for high Ki67 (≥10%) well-differentiated endocrine carcinoma stagingRonan Abgral, Sophie Leboulleux, Désirée Déandreis, et al.
Neuroendocrinology|June 9, 2020
Long-Term Results after Surgical Resection of Peritoneal Metastasis from Neuroendocrine TumorsLéonor Benhaim, Matthieu Faron, Julien Hadoux, et al.
Endocrine-Related Cancer|February 26, 2009
Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinomaCosimo Durante, Houda Boukheris, Clarisse Dromain, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
Bevacizumab plus capecitabine in patients with progressive advanced well-differentiated neuroendocrine tumors of the gastro-intestinal (GI-NETs) tract (BETTER trial)--a phase II non-randomised trialEmmanuel Mitry, Thomas Walter, Eric Baudin, et al.
The Journal of Clinical Endocrinology and Metabolism|March 31, 2017
Surgery for Neck Recurrence of Differentiated Thyroid Cancer: Outcomes and Risk FactorsLivia Lamartina, Isabelle Borget, Haitham Mirghani, et al.
Oncotarget|January 5, 2018
Identifying mitotane-induced mitochondria-associated membranes dysfunctions: metabolomic and lipidomic approachesSégolène Hescot, Larbi Amazit, Marie Lhomme, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 15, 2011
Magnetic resonance imaging versus endoscopic ultrasonography for the detection of pancreatic tumours in multiple endocrine neoplasia type 1Coralie Barbe, Arnaud Murat, Benoit Dupas, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 12, 2022
Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survivalArnaud Jannin, Livia Lamartina, Coralie Moutarde, et al.
Endocrinology, Diabetes & Metabolism Case Reports|June 15, 2016
Dyslipidemia causes overestimation of plasma mitotane measurementsAngelo Paci, Ségolène Hescot, Atmane Seck, et al.
Pageof 25